Skip to content
DefDex

Federal award

ASURAGEN INCORPORATED

W81K0022P0237

Contract

Obligated and Ceiling

Obligated (net)
$552,493.00
Ceiling (potential value, not spending)
$737,873.00
Current value
$737,873.00
Gross positive obligations
$760,868.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ASURAGEN INCORPORATED · E8M9NXN4X4Y7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ASURAGEN INCORPORATED · E8M9NXN4X4Y7
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0022P0237
Award type code
B
Actions
13 · Sep 8, 2022 to Apr 17, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 17, 2026FY2026P00012G$0.00
—
Dec 5, 2025FY2026P00011C−$100,940.00
—
Nov 25, 2025FY2026P00010C$178,300.00
—
Jul 18, 2025FY2025P00009C−$2,375.00
—
Apr 22, 2025FY2025P00008G$0.00
—
Nov 21, 2024FY2025P00007C$171,490.00
—
Apr 26, 2024FY2024P00006G$0.00
—
Dec 18, 2023FY2024P00005B$180,888.00
—
Sep 19, 2023FY2023P00004C$72,600.00
—
Aug 7, 2023FY2023P00003G$0.00
—
Jul 21, 2023FY2023P00002B−$105,060.00
—
Nov 2, 2022FY2023P00001C$157,590.00
—
Sep 8, 2022FY20220—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.